Retinoblastoma Binding Protein 9 (RBBP9) Antibody

Product Graph
637€ (100 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Retinoblastoma Binding Protein 9 (RBBP9) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx115152
tested applications
ELISA, WB, IHC

Description

Retinoblastoma Binding Protein 9 Antibody is a Rabbit Polyclonal antibody against Retinoblastoma Binding Protein 9.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Target: Retinoblastoma Binding Protein 9 (RBBP9)
Immunogen: Human RBBP9.
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Antigen Affinity Chromatography.
Size 1
100 µl
Form
Liquid
Tested Applications
ELISA, WB, IHC
Buffer
PBS, pH 7.3, containing 0.1% Sodium Azide and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
O75884
Gene ID
10741
NCBI Accession
NP_006597.2, NM_006606.2
OMIM
602908
Background
Antibody anti-RBBP9
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Descripción

Related Products

FNab07154

RBBP9 antibody

May play a role in the transformation process due to its capacity to confer resistance to the growth-inhibitory effects of TGF-beta1 through interaction with retinoblastoma and the subsequent displacement of E2F-1.

Ver Producto
FNab07155

RBBP9 antibody

May play a role in the transformation process due to its capacity to confer resistance to the growth-inhibitory effects of TGF-beta1 through interaction with retinoblastoma and the subsequent displacement of E2F-1.

Ver Producto
FNab07156

RBBP9 antibody

May play a role in the transformation process due to its capacity to confer resistance to the growth-inhibitory effects of TGF-beta1 through interaction with retinoblastoma and the subsequent displacement of E2F-1.

Ver Producto